Skip to main content

Advertisement

SpringerLink
Log in

The additional cancer yield of clinical breast examination in screening of women at hereditary increased risk of breast cancer: a systematic review

  • Review
  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

ABSTRACT

Women at hereditary increased risk of breast cancer are subjected to frequent clinical breast examination (CBE) and radiological evaluation of the breasts. This review appraises the additional cancer yield by CBE in screening of women at increased risk of breast cancer who are also subjected to frequent radiological evaluation. A literature search was conducted to identify all prospective studies on the additional value of CBE in screening of women at increased risk of breast cancer. Quality appraisal of included studies was performed using the QUADAS-2 tool. A total of 514 citations were identified. Relevant literature was scarce and highly heterogeneous. Seven prospective studies were included for review of which two studies reported additional cancer yield of CBE (3 and 5 % of total cancer cases). These two studies reported lower screen detection (77 and 80 %) compared to the studies in which no additional cases were detected by CBE (screen detection ≥94 %). Current literature on CBE in screening of women at increased risk of breast cancer is insufficient. However, it suggests that the additional cancer yield by performing CBE is minimal or absent. Reconsideration of the role of CBE in intensified screening might be warranted.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127(12):2893–2917

    Article  CAS  PubMed  Google Scholar 

  2. Berry DA, Cronin KA, Plevritis SK, Fryback DG, Clarke L, Zelen M, Mandelblatt JS, Yakovlev AY, Habbema JD, Feuer EJ (2005) Effect of screening and adjuvant therapy on mortality from breast cancer. N Engl J Med 353(17):1784–1792

    Article  CAS  PubMed  Google Scholar 

  3. Duffy SW, Tabar L, Chen HH, Holmqvist M, Yen MF, Abdsalah S, Epstein B, Frodis E, Ljungberg E, Hedborg-Melander C, Sundbom A, Tholin M, Wiege M, Akerlund A, Wu HM, Tung TS, Chiu YH, Chiu CP, Huang CC, Smith RA, Rosen M, Stenbeck M, Holmberg L (2002) The impact of organized mammography service screening on breast carcinoma mortality in seven Swedish counties. Cancer 95(3):458–469

    Article  PubMed  Google Scholar 

  4. NABON National Guideline Breast Cancer (2012) http://www.oncoline.nl/uploaded/docs/mammacarcinoom/Dutch%20Breast%20Cancer%20Guideline%202012.pdf

  5. Collaborative Group on Hormonal Factors in Breast Cancer (2001) Familial breast cancer: collaborative reanalysis of individual data from 52 epidemiological studies including 58,209 women with breast cancer and 101,986 women without the disease. Lancet 358(9291):1389–1399

    Article  Google Scholar 

  6. Ford D, Easton DF, Stratton M, Narod S, Goldgar D, Devilee P, Bishop DT, Weber B, Lenoir G, Chang-Claude J, Sobol H, Teare MD, Struewing J, Arason A, Scherneck S, Peto J, Rebbeck TR, Tonin P, Neuhausen S, Barkardottir R, Eyfjord J, Lynch H, Ponder BA, Gayther A, Zelada-Hedman M (1998) Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The breast cancer linkage consortium. Am J Hum Genet 62(3):676–689

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  7. Lord SJ, Lei W, Craft P, Cawson JN, Morris I, Walleser S, Griffiths A, Parker S, Houssami N (2007) A systematic review of the effectiveness of magnetic resonance imaging (MRI) as an addition to mammography and ultrasound in screening young women at high risk of breast cancer. Eur J Cancer 43(13):1905–1917

    Article  CAS  PubMed  Google Scholar 

  8. Gotzsche PC, Jorgensen KJ (2013) Screening for breast cancer with mammography. Cochrane Database Syst Rev 6:CD001877

    PubMed  Google Scholar 

  9. Nelson HD, Tyne K, Naik A, Bougatsos C, Chan BK, Humphrey L (2009) Screening for breast cancer: an update for the U.S. Preventive services task force. Ann Intern Med 151(10):727–742

    Article  PubMed Central  PubMed  Google Scholar 

  10. Griffin JL, Pearlman MD (2010) Breast cancer screening in women at average risk and high risk. Obstet Gynecol 116(6):1410–1421

    Article  PubMed  Google Scholar 

  11. Antoniou A, Pharoah PD, Narod S, Risch HA, Eyfjord JE, Hopper JL, Loman N, Olsson H, Johannsson O, Borg A, Pasini B, Radice P, Manoukian S, Eccles DM, Tang N, Olah E, Anton-Culver H, Warner E, Lubinski J, Gronwald J, Gorski B, Tulinius H, Thorlacius S, Eerola H, Nevanlinna H, Syrjakoski K, Kallioniemi OP, Thompson D, Evans C, Peto J, Lalloo F, Evans DG, Easton DF (2003) Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet 72(5):1117–1130

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  12. van der Groep P, Bouter A, van der Zanden R, Siccama I, Menko FH, Gille JJ, van KC, van der Wall E, Verheijen RH, van Diest PJ (2006) Distinction between hereditary and sporadic breast cancer on the basis of clinicopathological data. J Clin Pathol 59(6):611–617

    Article  PubMed Central  PubMed  Google Scholar 

  13. Kriege M, Brekelmans CT, Boetes C, Besnard PE, Zonderland HM, Obdeijn IM, Manoliu RA, Kok T, Peterse H, Tilanus-Linthorst MM, Muller SH, Meijer S, Oosterwijk JC, Beex LV, Tollenaar RA, de Koning HJ, Rutgers EJ, Klijn JG (2004) Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition. N Engl J Med 351(5):427–437

    Article  CAS  PubMed  Google Scholar 

  14. Warner E, Hill K, Causer P, Plewes D, Jong R, Yaffe M, Foulkes WD, Ghadirian P, Lynch H, Couch F, Wong J, Wright F, Sun P, Narod SA (2011) Prospective study of breast cancer incidence in women with a BRCA1 or BRCA2 mutation under surveillance with and without magnetic resonance imaging. J Clin Oncol 29(13):1664–1669

    Article  PubMed  Google Scholar 

  15. Kuhl CK, Kuhn W, Schild H (2005) Management of women at high risk for breast cancer: new imaging beyond mammography. Breast 14(6):480–486

    Article  CAS  PubMed  Google Scholar 

  16. Feigin KN, Keating DM, Telford PM, Cohen MA (2006) Clinical breast examination in a comprehensive breast cancer screening program: contribution and cost. Radiology 240(3):650–655

    Article  PubMed  Google Scholar 

  17. Whiting PF, Rutjes AW, Westwood ME, Mallett S, Deeks JJ, Reitsma JB, Leeflang MM, Sterne JA, Bossuyt PM (2011) QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med 155(8):529–536

    Article  PubMed  Google Scholar 

  18. Tilanus-Linthorst MM, Bartels CC, Obdeijn AI, Oudkerk M (2000) Earlier detection of breast cancer by surveillance of women at familial risk. Eur J Cancer 36(4):514–519

    Article  CAS  PubMed  Google Scholar 

  19. Warner E, Plewes DB, Shumak RS, Catzavelos GC, Di Prospero LS, Yaffe MJ, Goel V, Ramsay E, Chart PL, Cole DE, Taylor GA, Cutrara M, Samuels TH, Murphy JP, Murphy JM, Narod SA (2001) Comparison of breast magnetic resonance imaging, mammography, and ultrasound for surveillance of women at high risk for hereditary breast cancer. J Clin Oncol 19(15):3524–3531

    CAS  PubMed  Google Scholar 

  20. Warner E, Plewes DB, Hill KA, Causer PA, Zubovits JT, Jong RA, Cutrara MR, DeBoer G, Yaffe MJ, Messner SJ, Meschino WS, Piron CA, Narod SA (2004) Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination. JAMA 292(11):1317–1325

    Article  CAS  PubMed  Google Scholar 

  21. Rijnsburger AJ, Obdeijn IM, Kaas R, Tilanus-Linthorst MM, Boetes C, Loo CE, Wasser MN, Bergers E, Kok T, Muller SH, Peterse H, Tollenaar RA, Hoogerbrugge N, Meijer S, Bartels CC, Seynaeve C, Hooning MJ, Kriege M, Schmitz PI, Oosterwijk JC, de Koning HJ, Rutgers EJ, Klijn JG (2010) BRCA1-associated breast cancers present differently from BRCA2-associated and familial cases: long-term follow-up of the Dutch MRISC screening study. J Clin Oncol 28(36):5265–5273

    Article  CAS  PubMed  Google Scholar 

  22. Kuhl C, Weigel S, Schrading S, Arand B, Bieling H, Konig R, Tombach B, Leutner C, Rieber-Brambs A, Nordhoff D, Heindel W, Reiser M, Schild HH (2010) Prospective multicenter cohort study to refine management recommendations for women at elevated familial risk of breast cancer: the EVA trial. J Clin Oncol 28(9):1450–1457

    Article  PubMed  Google Scholar 

  23. Trop I, Lalonde L, Mayrand MH, David J, Larouche N, Provencher D (2010) Multimodality breast cancer screening in women with a familial or genetic predisposition. Curr Oncol 17(3):28–36

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  24. Sardanelli F, Podo F, Santoro F, Manoukian S, Bergonzi S, Trecate G, Vergnaghi D, Federico M, Cortesi L, Corcione S, Morassut S, Di MC, Cilotti A, Martincich L, Calabrese M, Zuiani C, Preda L, Bonanni B, Carbonaro LA, Contegiacomo A, Panizza P, Di CE, Savarese A, Crecco M, Turchetti D, Tonutti M, Belli P, Maschio AD (2011) Multicenter surveillance of women at high genetic breast cancer risk using mammography, ultrasonography, and contrast-enhanced magnetic resonance imaging (the high breast cancer risk italian 1 study): final results. Invest Radiol 46(2):94–105

    Article  PubMed  Google Scholar 

  25. Houlston RS, McCarter E, Parbhoo S, Scurr JH, Slack J (1992) Family history and risk of breast cancer. J Med Genet 29(3):154–157

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  26. Claus EB, Risch N, Thompson WD (1994) Autosomal dominant inheritance of early-onset breast cancer. Implications for risk prediction. Cancer 73(3):643–651

    Article  CAS  PubMed  Google Scholar 

  27. Berry DA, Iversen ES Jr, Gudbjartsson DF, Hiller EH, Garber JE, Peshkin BN, Lerman C, Watson P, Lynch HT, Hilsenbeck SG, Rubinstein WS, Hughes KS, Parmigiani G (2002) BRCAPRO validation, sensitivity of genetic testing of BRCA1/BRCA2, and prevalence of other breast cancer susceptibility genes. J Clin Oncol 20(11):2701–2712

    Article  CAS  PubMed  Google Scholar 

  28. Barton MB, Harris R, Fletcher SW (1999) The rational clinical examination. Does this patient have breast cancer? The screening clinical breast examination: should it be done? How? JAMA 282(13):1270–1280

    Article  CAS  PubMed  Google Scholar 

  29. Boyd NF, Sutherland HJ, Fish EB, Hiraki GY, Lickley HL, Maurer VE (1981) Prospective evaluation of physical examination of the breast. Am J Surg 142(3):331–334

    Article  CAS  PubMed  Google Scholar 

  30. Chamberlain J, Rogers P, Price JL, Ginks S, Nathan BE, Burn I (1975) Validity of clinical examination and mammography as screening tests for breast cancer. Lancet 2(7943):1026–1030

    Article  CAS  PubMed  Google Scholar 

  31. Thomas DC, Spitzer WO, MacFarlane JK (1981) Inter-observer error among surgeons and nurses in presymptomatic detection of breast disease. J Chronic Dis 34(12):617–626

    Article  CAS  PubMed  Google Scholar 

  32. Yu J, Park A, Morris E, Liberman L, Borgen PI, King TA (2008) MRI screening in a clinic population with a family history of breast cancer. Ann Surg Oncol 15(2):452–461

    Article  PubMed  Google Scholar 

  33. Fakkert IE, Jansen L, Meijer K, Kok T, Oosterwijk JC, Mourits MJ, de Bock GH (2011) Breast cancer screening in BRCA1 and BRCA2 mutation carriers after risk reducing salpingo-oophorectomy. Breast Cancer Res Treat 129(1):157–164

    Article  PubMed  Google Scholar 

  34. Maurice A, Evans DG, Affen J, Greenhalgh R, Duffy SW, Howell A (2012) Surveillance of women at increased risk of breast cancer using mammography and clinical breast examination: further evidence of benefit. Int J Cancer 131(2):417–425

    Article  CAS  PubMed  Google Scholar 

  35. Porter ME (2010) What is value in health care? N Engl J Med 363(26):2477–2481

    Article  CAS  PubMed  Google Scholar 

  36. Tabar L, Vitak B, Chen TH, Yen AM, Cohen A, Tot T, Chiu SY, Chen SL, Fann JC, Rosell J, Fohlin H, Smith RA, Duffy SW (2011) Swedish two-county trial: impact of mammographic screening on breast cancer mortality during 3 decades. Radiology 260(3):658–663

    Article  PubMed  Google Scholar 

  37. Miller AB, Wall C, Baines CJ, Sun P, To T, Narod SA (2014) Twenty five year follow-up for breast cancer incidence and mortality of the Canadian National Breast Screening Study: randomised screening trial. BMJ 348:g366

    Article  PubMed Central  PubMed  Google Scholar 

Download references

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical standards

No new experiments were conducted.

Author information

Authors and Affiliations

  1. Department of Surgery, Leiden University Medical Center, Albinusdreef 2, 2300 RC, Leiden, The Netherlands

    Toni Roeke, Annelotte C. M. van Bommel, Marlien P. Gaillard-Hemmink, Henk H. Hartgrink, Wilma E. Mesker & Rob A. E. M. Tollenaar

Authors
  1. Toni Roeke
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Annelotte C. M. van Bommel
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Marlien P. Gaillard-Hemmink
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Henk H. Hartgrink
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Wilma E. Mesker
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Rob A. E. M. Tollenaar
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Toni Roeke.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (PDF 41 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Roeke, T., van Bommel, A.C.M., Gaillard-Hemmink, M.P. et al. The additional cancer yield of clinical breast examination in screening of women at hereditary increased risk of breast cancer: a systematic review. Breast Cancer Res Treat 147, 15–23 (2014). https://doi.org/10.1007/s10549-014-3074-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10549-014-3074-8

Keywords

Search

Navigation